We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 818

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

The perils and promise of 3D printing: are DIY life sciences in your future?

  • Drinker Biddle & Reath LLP
  • -
  • USA
  • -
  • May 13 2013

With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used to produce guns

Data protection: defining innovative drug in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 22 2013

Canada amended its Data Protection Regulations in 2006 to provide protection for innovative drugs in a second attempt to implement Canada's 1994

Intellectual property, media and IT - 1st quarter 2013

  • Cuatrecasas Gonçalves Pereira
  • -
  • Portugal
  • -
  • April 8 2013

In its Judgment no. 22013, the Supreme Administrative Court D.R (Portuguese official gazette) No. 20, Series I of 2013-01-29 was decided that

Ninth Circuit to consider impact of trial court error in admitting expert testimony

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 4 2013

In related cases that could have implications for intellectual property, consumer safety and complex litigation where resolution of the dispute

Ukraine adopts compulsory licensing of pharmaceutical patents

  • Asters
  • -
  • Ukraine
  • -
  • March 25 2013

Ukraine is harmonising its national legislation with EU requirements on the compulsory licensing of pharmaceutical patents, which will allow

News bytes - March 7, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 7 2013

The U.S. Patent and Trademark Office (USPTO) seeks public comments by May 3, 2013, on "information requirements related to civil actions and claims

Leave to appeal to the Court of Appeal Re: motion to strike pleadings granted in respect of claims to unjust enrichment, denied in respect of claims under the Trade-Marks Act

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 6 2013

In this case, Apotex has sued Eli Lilly for damages pursuant to s. 8 of the Patented Medicines (Notice of Compliance) Regulations. Eli Lilly brought a

Top 10 steps global life sciences companies should take in 2013

  • Sidley Austin LLP
  • -
  • USA
  • -
  • March 1 2013

Engage in US budget and deficit reduction process. As governments, including the US and China, search for the means to fund priorities or reduce

National case law

  • Cuatrecasas Gonçalves Pereira
  • -
  • Portugal
  • -
  • February 28 2013

The Judgment n. ยบ 22013 of the Constitutional Court ruled unconstitutional the rule of no. 5 of article 188 of the Medicinal Products Act, the

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy